期刊文献+

视网膜母细胞瘤高迁移率族蛋白A、MIB-1标记指数和let-7的表达及其相关性分析 被引量:1

The expression and relationship of high-mobility group A, MIB labeling index and let-7 in retinoblastoma
原文传递
导出
摘要 目的观察分析视网膜母细胞瘤(RB)肿瘤组织中高迁移率族蛋白A(HMGA)1和HMGA2、MIB-1标记指数(LI)及1et-7的表达及其相关性。方法44例RB肿瘤组织标本纳人研究。其中,低分化组织标本11例,高分化组织标本33例。侵袭性肿瘤组织标本8例,非侵袭性肿瘤组织标本36例。采用免疫组织化学染色方法检测RB肿瘤组织标本中HMGA1、HMGA2及MIB-1LI的表达。HMGA1、HMGA2表达判定标准:以0为无表达,1%~10%为低度表达,11%~50%为中度表达,〉50%为高度表达;MIB-1LI表达判定标准:以0为无表达,1%~40%为低度表达,〉40%为高度表达。采用逆转录聚合酶联反应检测let-7的表达;以≥80%为无明显下降,60%~79%为中度下降,〈60%为高度下降。结果44例标本中,HMGA1无表达14例,占32%;低度表达11例,占25%;中度表达10例,占23%;高度表达9例,占20%。低分化组织标本的HMGA1表达率高于高分化组织标本,差异有统计学意义(χ2=11.3,P〈0.01)。侵袭性与非侵袭性肿瘤组织标本的HMGAl表达率比较,差异无统计学意义(χ2=5.9,P〉0.05)。HMGA2无表达11例,占25%;低度表达11例,占25%;中度表达9例,占20%;高度表达13例,占30%。低分化组织标本的HMGA2表达率高于高分化组织标本,差异有统计学意义(χ2=20.9,P〈0.05)。侵袭性肿瘤组织标本的HMGA2表达率高于非侵袭性肿瘤组织标本,差异有统计学意义(χ2=8.7,P〈0.05)。MIB-1LI无表达4例,占9%;低度表达18例,占41%;高度表达22例,占50%。低分化组织标本的MIB-1LI表达水平高于高分化组织标本,差异有统计学意义(t=5.2,P〈0.05)。侵袭性肿瘤组织标本的MIB-1LI表达水平高于非侵袭性肿瘤组织标本,但差异无统计学意义(t=-1.1,P〉0.05)。1et-7表达无明显下降27例,占61%,中度下降8例,占18%,高度下降9例,占21%。相关性分析结果显示,MIB-1LI表达与HMGA1和HMGA2表达呈显著正相关(r=0.327、0.602,P〈0.05);let-7表达与HMGA1、HMGA2表达及MIB-1LI表达均呈负相关(r=-0.247、-0.310、-0.392,P〈0.05)。结论在RB肿瘤组织中HMGA1、HMGA2和MIB-1LI均呈现高表达,let-7表达下降。1et-7有可能抑制HMGA1和HMGA2的表达。 Objective To observe the expression and relationship of high-mobility group A(HMGA) 1, HMGA2, MIB-1 labeling index (LI) and let-7 in retinoblastoma (RB). Methods Forty-four RB samples were studied, including 11 poorly-differentiated samples, 33 well-differentiated samples; eight invasive and 36 non-invasive samples. The expression of HMGA1, HMGA2 and MIB-1 LI in RB were analyzed by immunohistochemitry. The HMGA1, HMGA2 were scored on a scale of 0 to high expression. 0: no expression; low: 1% - 10% ; medium.. 11 % - 50% ; high: 〉50%. The MIB LI were scored on a scale of 0 to high expression. 0: no expression; low.. 1% - 40%; high: 〉 40%. Semiquantitative reverse transcription-polymerase chain reaction was used to assay the let-7 expression level: ≥80% showed no significantly decreased expression;60% - 79% showed medium decrease in expression; 〈 60% highly decreased in expression. Results In 44 RB samples, there were 14 cases with no HMGA1 expression(32%), 11 cases with low expression (25%), 10 cases with medium expression (23%), and nine cases with high expression (20%). Expression level of HMGA1 was significantly higher in poorly differentiated RB than in well-differentiated RB (χ2= 11.3, P〈0.01) ; however, no statistically significant difference was found between invasive tumors and noninvasive tumors (χ2=5.9, P〉0.05). There were 11 cases with no HMGA2 expression (25%), 11 cases with low expression (25%), nine cases with medium expression (20 %), and 13 cases with high expression (30 %). Expression level of HMGA2 was significantly higher in poorly differentiated and invasive RB than in well-differentiated and noninvasive RB respectively (χ2 = 20.9, 8.7; P〈0.05). There were 4 cases with no MIB-1 LI expression (9%), 18 cases with low expression (41 % ), and 22 cases with high expression (50 %). Expression level of MIB-1 LI was significantly higher in poorly differentiated RB than in well-differentiated RB (t=5.2, P〈0.05). Higher expression of MIB-1 LI was found in invasive tumors than in noninvasive tumors, with no significant difference (t=- 1.1, P〉 0.05). Twenty-seven cases had no significantly decreased expression of let-7 (61%). There were eight cases with medium decreased expression (18%) and nine cases with highly decreased expression (21%). Correlation analyses revealed that MIB-1 LI expression significantly correlated with HMGAland HMGA2 proteins (r=0. 327, 0. 602; P〈0.05). A significantly inverse correlation existed between let-7 expression and HMGA1, HMGA2 proteins and MIB-1 LI respectively (r=-0.247,-0.310, -0.392; P〈0.05). Conclusions Overexpression of HMGA1, HMGA2 and M1B-1 LI and down regulation of let-7 were demonstrated in RB. Supplying let-7 to RB cells can possibly inhibit HMGA1 and HMGA2 expression.
出处 《中华眼底病杂志》 CAS CSCD 北大核心 2012年第6期560-564,共5页 Chinese Journal of Ocular Fundus Diseases
基金 山东省科学技术发展计划(2012GSF12121) 山东大学自主创新基金(2012ZD025)
关键词 视网膜母细胞瘤 代谢 视网膜母细胞瘤蛋白质 肿瘤标记 生物学 基因 肿瘤抑制 Retinoblastoma/metabolism Retinoblastoma protein Tumor makers, biological Genes, tumor suppressor
  • 相关文献

参考文献23

  • 1Corson TW,Gallie BL. One hit, two hits, three hits,more.Genomic changes in the development of retinoblastoma. GenesChromosomes Cancer, 2007,46 : 617-634.
  • 2Fusco A, Fedele M. Roles of HMGA proteins in cancer. NatRev Cancer, 2007, 7:899-910.
  • 3Caldas C,Brenton JD. Sizing up miRNAs as cancer genes. NatMed, 2005, 11:712-714.
  • 4Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with arole in cancer. Nat Rev Cancer, 2006 6 : 259-269.
  • 5Reinhart BJ, Slack FJ, Basson M, et al. The 21-nucleotide let-7RNA regulates developmental timing in caenorhabditis elegans.Nature, 2000, 403:901-906.
  • 6Johnson CD, Esquela-Kerscher A,Stefani G,et al. The let-7microRNA represses cell proliferation pathways in human cells.Cancer Res, 2007, 67:7713-7722.
  • 7Abramson DH. Retinoblastoma in the 20th century: pastsuccess and future challenges the Weisenfeld lecture. InvestOphthalmol Vis Sci, 2005,46 : 2683-2691.
  • 8Rahman MM, Qian ZR, Wang EL, et al. Frequentoverexpression of HMGA1 and 2 ingastroenteropancreaticneuroendocrine tumours and its relationship to let-7downregulation. Br J Cancer, 2009,100 : 501-510.
  • 9Reeves R, Nissen MS. The AT-DNA-binding domain ofmammalian high mobility group I chromosomal proteins: anovel peptide motif for recognizing DNA structure. J Biol Chem,1990, 265:8573-8582.
  • 10Thanos D,Maniatis T. The high mobility group protein HMG I(Y) is required for NF-kappa B-dependent virus induction of thehuman IFN-beta gene. Cell, 1992,71:777-789.

同被引文献20

  • 1Calzolari A. Transferrin receptor 2 is frequently expressed in human cancer cell lines [ J]. Blood CeUs Mol Dis, 2007,39 ( 1 ) : 82- 91.
  • 2Chang J ,Jallouli Y, Kroubi M. Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood-brain barnerr J]. Int J Pharm,2009 ,379(2) :285-292.
  • 3Qin Y, Chen H, Zhang Q, Wang X, Yuan W, Kuai R, et al. Liposome formulated with TAT-modified cholesterol for improving brain delivery and therapeutic efficacy on brain glioma in animals[J]. Int J Pharm,2011 ,420(2) :304-312.
  • 4Kuai R. Targeted delivery of cargoes into a murine solid tumor by a cell-penetrating peptide and cleavable poly (ethylene glycol) comodified Iiposomal delivery system via systemic administration[ J]. Mol Pharm,2011 ,8 (6) :2151-216l.
  • 5Kuai R. Efficient delivery of payload into tumor cells in a controlled manner by TAT and thiolytic cleavable PEG co-modified Iiposomes[ J]. Mol Pharm,2010, 7 (5) : 1816-1826.
  • 6Zhang Q, Tang J,Fu L,Ran R,Liu Y, Yuan M,et at. A pH-responsive a-helical cell penetrating peptide-mediated Iiposomal delivery system [ J]. Biomaterials ,2013,34(32) :7980-7993.
  • 7Qin Y. Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery [J]. Int J Pharm , 2011 ,419 ( 1-2) : 85-95.
  • 8Qian ZM. Targeted drug delivery via the transferring receptormediated endocytosis pathway [ J ]. Pharmacal Rev, 2002, 54 (4) :561-587.
  • 9Suzuki R. Effective anti-tumor activity of oxaliplatin encapsulated in transferrin-PEG-liposome[ J]. Int J Pharm, 2008,346 ( 1- 2) : 143-150.
  • 10Pappalardo J. Improved transfection of spleen-derived antigenpresenting cells in culture using TAT p-liposomes [J]. J Contr-ol Release ,2009,134 ( 1 ) :41-46.

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部